Piper Sandler upgraded shares of Trupanion (NASDAQ:TRUP – Free Report) from a neutral rating to an overweight rating in a research note released on Thursday, MarketBeat reports. They currently have $57.00 price target on the financial services provider’s stock.
Several other equities research analysts have also recently commented on TRUP. Northland Securities increased their price objective on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus lifted their price target on shares of Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Trupanion currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.33.
Read Our Latest Research Report on Trupanion
Trupanion Stock Up 3.8 %
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the prior year, the firm posted ($0.10) EPS. The firm’s quarterly revenue was up 14.6% on a year-over-year basis. Equities research analysts forecast that Trupanion will post -0.2 EPS for the current year.
Insider Activity
In other news, SVP Emily Dreyer sold 3,100 shares of the firm’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $54.85, for a total transaction of $170,035.00. Following the sale, the senior vice president now directly owns 24,708 shares in the company, valued at $1,355,233.80. This trade represents a 11.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Steve Weinrauch sold 11,916 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $53.00, for a total transaction of $631,548.00. Following the completion of the transaction, the executive vice president now directly owns 48,978 shares of the company’s stock, valued at $2,595,834. This represents a 19.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,597 shares of company stock valued at $1,522,082 in the last ninety days. Corporate insiders own 5.50% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in TRUP. FMR LLC grew its holdings in Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after buying an additional 1,170,202 shares in the last quarter. Renaissance Technologies LLC purchased a new position in Trupanion during the second quarter valued at $4,739,000. Marshall Wace LLP increased its holdings in Trupanion by 11.9% in the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after acquiring an additional 116,496 shares during the last quarter. Barclays PLC lifted its stake in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after purchasing an additional 47,262 shares in the last quarter. Finally, OmniStar Financial Group Inc. bought a new position in shares of Trupanion during the 3rd quarter valued at about $535,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories
- Five stocks we like better than Trupanion
- Industrial Products Stocks Investing
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Trading Stocks: RSI and Why it’s Useful
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.